Repronovo

Patients

During JPM2026, pharmaphorum spoke with Jean Duvall, CEO of Repronovo, a company that’s working on new infertility treatments for men and women.

News

Novo adds Anthropic AI models and Claude Science to its drug discovery toolkit in a bid to become "the world's most AI-driven healthcare company."

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.